Toll Group is investing $100 million into healthcare services across the Asia Pacific, a move which will deliver economic benefits to Australia.
This investment will grow supply chain capabilities and assets and provide scalability for customers across Southeast Asia and beyond.
Federal Minister for Trade and Tourism, Don Farrell, welcomed the investment while attending an AustCham event in Singapore.
The event was part of a four-day visit for the Singapore-Australia Joint Ministerial Committee – an annual meeting which underlines the importance and depth of the relationship between Australia and Singapore.
“Toll is showing what is possible and it is precisely the sort of investment that we were aiming to support when the Government launched our Southeast Asia Economic Strategy to 2040,” Farrell said.
“When Australian businesses go out into the region, the benefits come home.”
Austrade Senior Trade and Investment Commissioner, Singapore, Kirstyn Thomson, said Toll’s investments bring to life the vision that was laid out in Invested: Australia’s Southeast Asia Economic Strategy to 2040.
“Australia has a globally integrated and highly advanced healthcare industry,” she said.
“Toll’s investment into the region will help more Australian innovators to export and aims to ensure the safe and secure distribution of pharmaceutical, therapies and healthcare devices throughout the region.”
The company’s Australian investments include the construction of several specialist healthcare facilities such as a state-of-the-art centre in Melbourne for CSL Seqirus and a new facility in Richlands, Queensland, for vaccine distribution.
Additionally, Toll is set to open a facility in Hazelmere, Western Australia, by mid-2025.
Toll Chief Enterprise Services Officer, Anna Green, emphasised the economic benefits of this investment.
“We anticipate this investment will generate hundreds of new jobs in Australia and Asia,” she said.
“In Australia, around 130 healthcare jobs have been added to Toll’s existing 6,000-plus strong workforce, which is expected to grow as further investments in property and technologies are made.”
This initiative, she said, will not only enhance Australia’s supply chain capabilities but also strengthen local economies by boosting digital and healthcare skills.
“Toll is well positioned to partner with Australian businesses as they enter and grow in Southeast Asia,” Green said.
“Our enhanced supply chain network and capacity will give Australian exporters access to a strategic hub in Southeast Asia, and proximity to Toll’s networks in key growth markets like Malaysia, Indonesia, and India.”
The post Toll Group announces $100M healthcare investment appeared first on Trailer Magazine.